A Mycobacteriophage-Based Vaccine Platform: SARS-CoV-2 Antigen Expression and Display
Open Access
- 23 November 2021
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 9 (12), 2414
- https://doi.org/10.3390/microorganisms9122414
Abstract
The explosion of SARS-CoV-2 infections in 2020 prompted a flurry of activity in vaccine development and exploration of various vaccine platforms, some well-established and some new. Phage-based vaccines were described previously, and we explored the possibility of using mycobacteriophages as a platform for displaying antigens of SARS-CoV-2 or other infectious agents. The potential advantages of using mycobacteriophages are that a large and diverse variety of them have been described and genomically characterized, engineering tools are available, and there is the capacity to display up to 700 antigen copies on a single particle approximately 100 nm in size. The phage body may itself be a good adjuvant, and the phages can be propagated easily, cheaply, and to high purity. Furthermore, the recent use of these phages therapeutically, including by intravenous administration, suggests an excellent safety profile, although efficacy can be restricted by neutralizing antibodies. We describe here the potent immunogenicity of mycobacteriophage Bxb1, and Bxb1 recombinants displaying SARS-CoV-2 Spike protein antigens.Keywords
Funding Information
- National Institute of Health (GM131729)
- Howard Hughes Medical Institute (GT12053)
- DSF Charitable Foundation (AKM)
This publication has 59 references indexed in Scilit:
- Display of the VP1 epitope of foot-and-mouth disease virus on bacteriophage T7 and its application in diagnosisJournal of Virological Methods, 2013
- Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis BFEMS Immunology & Medical Microbiology, 2011
- Dual expression system for assembling phage lambda display particle (LDP) vaccine to porcine Circovirus 2 (PCV2)Vaccine, 2010
- Immunogenicity of bacteriophage lambda particles displaying porcine Circovirus 2 (PCV2) capsid protein epitopesVaccine, 2009
- BRED: A Simple and Powerful Tool for Constructing Mutant and Recombinant Bacteriophage GenomesPLOS ONE, 2008
- Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in miceVaccine, 2008
- Ig-Like Domains on Bacteriophages: A Tale of Promiscuity and DeceitJournal of Molecular Biology, 2006
- Protein Chainmail: Catenated Protein in Viral CapsidsCell, 1998
- Phage display of intact domains at high copy number: A system based on SOC, the small outer capsid protein of bacteriophage T4Protein Science, 1996
- New use of BCG for recombinant vaccinesNature, 1991